Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.
The iLet Bionic Pancreas uses an adaptive closed-loop algorithm requiring only a user’s body weight for start-up and no additional insulin dosing parameters.
Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.
As part of California’s new budget, $50 million will go directly to the development of low-cost insulin products to increase access for patients with diabetes.
A team of researchers investigated whether changes in microRNA levels could be detected in whole-blood samples from children with HLA-conferred risk of type 1 diabetes.
Exercise plays an important part in treating diabetes, but physically active patients with type 1 diabetes face challenges to maintain normal blood-glucose levels.
A recent review underscores the possible adverse effects of ketogenic diets including increased risks for heart disease, cancer, diabetes, and kidney stones.
The researchers evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using data from an international study to glean information about people in developing countries.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
